|
NIDA Notes covers drug abuse research in the areas of treatment and prevention, epidemiology, neuroscience, behavioral science, health services, and AIDS. The publication reports on research; identifies resources; and promotes communication among clinicians, researchers, administrators, policymakers, and the public. Readers are encouraged to identify subject areas they would like to see highlighted.
NIDA Notes is a publication of the U.S. Government produced by the National Institute on Drug Abuse. Use of funds for printing this periodical has been approved by the Director of the Office of Management and Budget. Except for material specifically identified as copyrighted, all materials appearing in NIDA Notes are in the public domain and may be reproduced without permission. Citation of the source is appreciated.
Editor: David Anderson, Public Health Advisor, Public Information and Liaison Branch, Office of Science Policy and Communications, National Institute on Drug Abuse
Deputy Editor: Julie Ann Miller, Ph.D., MasiMax Resources, Inc.
Managing Editor: Andrew Keegan, MasiMax Resources, Inc.
Senior Writer: Lori Whitten, Ph.D., MasiMax Resources, Inc.
Associate Editor: Debra P. Davis, MasiMax Resources, Inc.
Design/Layout: Maggie Bray, MasiMax Resources, Inc.
Editorial Board: David Anderson, Chair; Public Health Advisor, Public Information and Liaison Branch, Office of Science Policy and Communications
Nicolette Borek, Ph.D., Research Psychologist, Division of Clinical Neuroscience and Behavioral Research
J.C. Comolli, Public Health Advisor, Division of Pharmacotherapies and Medical Consequences of Drug Abuse
Jennifer Elcano, M.A., Science Writer, Office of Science Policy and Communications
Lynda Erinoff, Ph.D., Associate Director, AIDS Research Program, Division of Epidemiology, Services and Prevention Research
Jacqueline Lloyd, Ph.D., Health Science Administrator, Division of Epidemiology, Services and Prevention Research
Marsha F. Lopez, Ph.D., Health Science Administrator, Division of Epidemiology, Services and Prevention Research
Gerald McLaughlin, Ph.D., Chief, Grants Review Branch, Office of Extramural Affairs
Mary Ellen Michel, Ph.D., Deputy Director, Center for the Clinical Trials Network
Ivan Montoya, M.D., M.P.H., Medical Officer, Division of Pharmacotherapies and Medical Consequences of Drug Abuse
Mary Pfeiffer, M.L.S., M.A.,Editor and Writer, Intramural Research Program
Kenzie Preston, Ph.D.,Chief, Clinical Pharmacology and Therapeutics Research Branch
Joni Rutter, Ph.D., Program Director, Genetics and Molecular Neurobiology Research Branch, Division of Basic Neuroscience and Behavioral Research
Anna Staton, M.P.A., Public Health Analyst, Office of Science Policy and Communications
Cora Lee Wetherington, Ph.D., Psychologist, Behavioral and Cognitive Science Research Branch, Division of Basic Neuroscience and Behavioral Research
This publication was produced and printed by MasiMax Resources, Inc., under Contract No. N01DA-4-1117 from the National Institute on Drug Abuse.
|
|
|